FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3216467874> ?p ?o ?g. }

• W3216467874 endingPage "224" @default.
• W3216467874 startingPage "217" @default.
• W3216467874 abstract "Prostate cancer (PCa) is a leading cause of cancer mortality in the male population commonly treated with androgen deprivation therapy (ADT) and relapsing as aggressive and androgen-independent castration-resistant prostate cancer (CRPC). In PCa the FGF/FGFR family of growth factors and receptors represents a relevant mediator of cancer growth, tumor-stroma interaction, and a driver of resistance and relapse to ADT. In the present work, we validate the therapeutic efficacy the FDA-approved FGFR inhibitor pemigatinib, in an integrated platform consisting of human and murine PCa cells, and the transgenic multistage TRAMP model of PCa that recapitulates both androgen-dependent and CRPC settings. Our results show for the first time that pemigatinib causes intracellular stress and cell death in PCa cells and prevents tumor growth in vivo and in the multistage model. In addition, the combination of pemigatinib with enzalutamide resulted in long-lasting tumor inhibition and prevention of CRPC relapse in TRAMP mice. These data are confirmed by the implementation of a stochastic mathematical model and in silico simulation. Pemigatinib represents a promising FDA-approved FGFR inhibitor for the treatment of PCa and CRPC alone and in combination with enzalutamide." @default.
• W3216467874 created "2021-12-06" @default.
• W3216467874 creator A5000915955 @default.
• W3216467874 creator A5000996859 @default.
• W3216467874 creator A5005942566 @default.
• W3216467874 creator A5007702218 @default.
• W3216467874 creator A5011886571 @default.
• W3216467874 creator A5013367044 @default.
• W3216467874 creator A5047882670 @default.
• W3216467874 creator A5056540508 @default.
• W3216467874 creator A5063574338 @default.
• W3216467874 creator A5068513157 @default.
• W3216467874 creator A5071464323 @default.
• W3216467874 creator A5079567385 @default.
• W3216467874 creator A5080776751 @default.
• W3216467874 date "2022-02-01" @default.
• W3216467874 modified "2023-10-05" @default.
• W3216467874 title "FGFR blockade by pemigatinib treats naïve and castration resistant prostate cancer" @default.
• W3216467874 cites W1552673178 @default.
• W3216467874 cites W1605841362 @default.
• W3216467874 cites W1776781495 @default.
• W3216467874 cites W1940272364 @default.
• W3216467874 cites W1960850967 @default.
• W3216467874 cites W1982887112 @default.
• W3216467874 cites W1982920486 @default.
• W3216467874 cites W2004632928 @default.
• W3216467874 cites W2005658600 @default.
• W3216467874 cites W2010057554 @default.
• W3216467874 cites W2026105816 @default.
• W3216467874 cites W2033414387 @default.
• W3216467874 cites W2099054500 @default.
• W3216467874 cites W2113194416 @default.
• W3216467874 cites W2113332865 @default.
• W3216467874 cites W2130801442 @default.
• W3216467874 cites W2131036707 @default.
• W3216467874 cites W2144110960 @default.
• W3216467874 cites W2148745019 @default.
• W3216467874 cites W2152350429 @default.
• W3216467874 cites W2235523093 @default.
• W3216467874 cites W2301685087 @default.
• W3216467874 cites W2308890438 @default.
• W3216467874 cites W2314920404 @default.
• W3216467874 cites W2618618401 @default.
• W3216467874 cites W2762381618 @default.
• W3216467874 cites W2809966743 @default.
• W3216467874 cites W3005243004 @default.
• W3216467874 cites W3007294163 @default.
• W3216467874 cites W3014482292 @default.
• W3216467874 cites W3021211757 @default.
• W3216467874 cites W3091935662 @default.
• W3216467874 cites W3111344382 @default.
• W3216467874 cites W4211024301 @default.
• W3216467874 doi "https://doi.org/10.1016/j.canlet.2021.11.030" @default.
• W3216467874 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34861311" @default.
• W3216467874 hasPublicationYear "2022" @default.
• W3216467874 type Work @default.
• W3216467874 sameAs 3216467874 @default.
• W3216467874 citedByCount "7" @default.
• W3216467874 countsByYear W32164678742023 @default.
• W3216467874 crossrefType "journal-article" @default.
• W3216467874 hasAuthorship W3216467874A5000915955 @default.
• W3216467874 hasAuthorship W3216467874A5000996859 @default.
• W3216467874 hasAuthorship W3216467874A5005942566 @default.
• W3216467874 hasAuthorship W3216467874A5007702218 @default.
• W3216467874 hasAuthorship W3216467874A5011886571 @default.
• W3216467874 hasAuthorship W3216467874A5013367044 @default.
• W3216467874 hasAuthorship W3216467874A5047882670 @default.
• W3216467874 hasAuthorship W3216467874A5056540508 @default.
• W3216467874 hasAuthorship W3216467874A5063574338 @default.
• W3216467874 hasAuthorship W3216467874A5068513157 @default.
• W3216467874 hasAuthorship W3216467874A5071464323 @default.
• W3216467874 hasAuthorship W3216467874A5079567385 @default.
• W3216467874 hasAuthorship W3216467874A5080776751 @default.
• W3216467874 hasConcept C121608353 @default.
• W3216467874 hasConcept C126322002 @default.
• W3216467874 hasConcept C143998085 @default.
• W3216467874 hasConcept C170493617 @default.
• W3216467874 hasConcept C2776551883 @default.
• W3216467874 hasConcept C2777899217 @default.
• W3216467874 hasConcept C2778468042 @default.
• W3216467874 hasConcept C2780192828 @default.
• W3216467874 hasConcept C2780940892 @default.
• W3216467874 hasConcept C2908647359 @default.
• W3216467874 hasConcept C502942594 @default.
• W3216467874 hasConcept C61367390 @default.
• W3216467874 hasConcept C71924100 @default.
• W3216467874 hasConcept C99454951 @default.
• W3216467874 hasConceptScore W3216467874C121608353 @default.
• W3216467874 hasConceptScore W3216467874C126322002 @default.
• W3216467874 hasConceptScore W3216467874C143998085 @default.
• W3216467874 hasConceptScore W3216467874C170493617 @default.
• W3216467874 hasConceptScore W3216467874C2776551883 @default.
• W3216467874 hasConceptScore W3216467874C2777899217 @default.
• W3216467874 hasConceptScore W3216467874C2778468042 @default.
• W3216467874 hasConceptScore W3216467874C2780192828 @default.
• W3216467874 hasConceptScore W3216467874C2780940892 @default.
• W3216467874 hasConceptScore W3216467874C2908647359 @default.
• W3216467874 hasConceptScore W3216467874C502942594 @default.

• next